Thursday, 23 May 2019

Pharma News

  • Sosei initiates oropharyngeal candidiasis trial

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    Singapore: Sosei Group's Japanese subsidiary initiated a phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis. The study is an open-label, randomised, multiple centr...Read more

  • AstraZeneca boosts drug pipeline with $272 mn deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2012

    Singapore: AstraZeneca and Ardelyx entered into a worldwide exclusive licensing agreement for the latter's NHE3 inhibitor programme, including the phase II-ready lead compound RDX5791, for ...Read more

  • NIH to develop therapeutics for nicotine addiction

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: The National Institutes of Health (NIH), US, has launched three projects that will focus on development of therapeutics for fragile X syndrome, nicotine addiction, and age-relat...Read more

  • Boehringer shuts Petersburg plant, axes 240 staff

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2013

    Singapore: Boehringer Ingelheim Chemicals is going to close its Petersburg plant at the end of 2014. The facility will continue normal operations through the remainder of 2013 and phase out...Read more

  • Firm shuts after Alzheimer's trial fails in monkeys

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    Singapore: US-based start-up Satori Pharmaceuticals shut down after running into safety problems in preclinical research of its lead program for Alzheimer's disease, according to FierceBiot...Read more

  • China to blacklist corrupt drugmakers

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2014

    Singapore: China has decided to introduce a healthcare corruption 'blacklist' this 2014 to nab drugmakers and medical device manufacturers found to have paid bribes. As part of its extende...Read more

  • Astellas, Cytokinetics sign $490 mn muscle deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: US-based Cytokinetics and Japan-based Astellas Pharma entered in a two-year collaboration focused on the R&D and commercialization of skeletal muscle activators. The primary ...Read more

  • Astellas, XenoPort launch Regnite in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2012

    Singapore: Astellas Pharma and XenoPort have launched Regnite (gabapentin enacarbil) extended-release tablets. Regnite is approved in Japan for the treatment of moderate-to-severe primary r...Read more

  • KHIDI, UAE armed forces sign healthcare MoA

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

    Singapore: Korea Health Industry Development Institute (KHIDI) has signed a memorandum of agreement (MoA) for healthcare cooperation with the UAE Armed Forces on November 21, 2012. The MoA...Read more

  • Karnataka pharma policy: Introduce clusters to enhance sector

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2013

    Bangalore: The Indian state of Karnataka, which houses the most number of life science firms in the country, unveiled its new pharmaceutical policy. The new policy intends to introduce the ...Read more

  • NZ firm to raise funds for Australia trial

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 to finance a multi-center phase IIB trial of MIS416 in patients with s...Read more

  • Bangalore is synonymous with Biotech: BIB 2014

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Feb, 2014

    Bangalore: The pioneers from the Biotechnology industry gathered at the Bangalore India Bio 2014, as if with a renewed hope, to strike a chord with those who matter in the industry globally...Read more

  • Taiwan orders removal of 33 drugs off shelves

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2013

    Singapore: Taiwan's Ministry of Health and Welfare has ordered the removal of 33 drugs from shelves, as they do not conform to their own description. Making the list of drugs public, the m...Read more

  • TSRI, Takeda expand research collaboration

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

    Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collaboration to search for new drug targets for a variety of diseases. The...Read more

  • Chinese police probe GSK staff for 'economic crimes'

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2013

    Singapore: The Chinese police have been investigating senior staff from the Chinese office of the British drug major GlaxoSmithKline (GSK) for suspected 'economic crimes' according to a st...Read more

  • ShangPharma completes merger

    Pharma |  Company results | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    ‎Singapore: ShangPharma, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, has completed the merger with ShangPharma Holdings, Shang...Read more

  • Japanese I'rom acquires 18% in Australian IDT

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

    Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the Tokyo Stock Exchange and is one of the leading providers of site manag...Read more

  • Indian drug approval mechanism under fire

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 Aug, 2012

    On May 8, when Mr Brajesh Pathak, chairman of India's parliamentary standing committee on health and family welfare, presented its report on the way Central Drugs Standards Control Organiza...Read more



Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls